Sonnet BioTherapeutics Holdings Inc logo

Sonnet BioTherapeutics Holdings Inc

STU:H3D (USA)   Ordinary Shares
€ 5.50 (0%) Jun 7
At Loss
P/B:
1.67
Market Cap:
€ 4.86M ($ 5.25M)
Enterprise V:
€ 1.54M ($ 1.66M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Sonnet BioTherapeutics Holdings Inc Valuation Measures